EGFR and chronic obstructive pulmonary disease: BIBW 2948 is the inhibitor of EGFR, and inhalation of BIBW 2948 (4-week treatment) reduced internalisation of EGFR but did not reduce mucin stores.179 Inhibition of TGF-β1 signalling may also be a useful therapeutic strategy in COPD.